Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers.

US stocks rallied on Monday as Wall Street braced for a packed week of high-profile earnings and the delayed release of key ...

Where to next for Tesla? Investors, at least for now, have signaled that they're willing to look at the longer-term picture.

Western Alliance stock drops 11% on lending risk concerns; learn what Q3 results and analyst insights mean for regional banks ...

American Express said its quarterly revenue climbed to a record high, as the card issuer benefited from refreshed high-end ...

JPMorgan analysts say that the market's top 30 AI names now account for about 44% of the value of the S&P 500.

Shares in EssilorLuxottica surged after the Ray-Ban maker reported an acceleration in quarterly revenue that smashed analysts' forecasts.

Sea Limited (NYSE:SE) rallied in early trading on Thursday after Bank of America fired off a Buy rating on the digital ...

Nvidia stock wavered Wednesday after the AI chip leader garnered additional business from British data center operator Nscale ...

For several years, SoFi Technologies (SOFI -7.91%) was out of favor among investors. Skepticism ran high about whether this company could live up to the grand vision touted by SoF ...

To offset the impact of U.S. tariffs, the company plans to strengthen its branding, cut costs and revise prices for some products in North America, it said. Uniqlo clothes are mostly made in countries ...